EDGAR Filing Documents for 0001437749-17-005131

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-17-005131

Filing Date

2017-03-23

Accepted

2017-03-23 16:11:12

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	nby20161231_10k.htm	10-K	2341302
2	EXHIBIT 4.1	ex4-1.htm	EX-4.1	112529
3	EXHIBIT 4.2	ex4-2.htm	EX-4.2	127901
4	EXHIBIT 4.3	ex4-3.htm	EX-4.3	119077
5	EXHIBIT 4.5	ex4-5.htm	EX-4.5	113553
6	EXHIBIT 10.7	ex10-7.htm	EX-10.7	23878
7	EXHIBIT 23.1	ex23-1.htm	EX-23.1	2872
8	EXHIBIT 31.1	ex31-1.htm	EX-31.1	10317
9	EXHIBIT 31.2	ex31-2.htm	EX-31.2	9968
10	EXHIBIT 32.1	ex32-1.htm	EX-32.1	4813
11	EXHIBIT 32.2	ex32-2.htm	EX-32.2	4660
18		a1.jpg	GRAPHIC	6743
19		nby20161231_10kimg005.gif	GRAPHIC	15698
	Complete submission text file	0001437749-17-005131.txt		11278796

Data Files

Seq	Description	Document	Type	Size
12	EXHIBIT 101.INS	nby-20161231.xml	EX-101.INS	2369276
13	EXHIBIT 101.SCH	nby-20161231.xsd	EX-101.SCH	99109
14	EXHIBIT 101.CAL	nby-20161231_cal.xml	EX-101.CAL	47580
15	EXHIBIT 101.DEF	nby-20161231_def.xml	EX-101.DEF	655385
16	EXHIBIT 101.LAB	nby-20161231_lab.xml	EX-101.LAB	550925
17	EXHIBIT 101.PRE	nby-20161231_pre.xml	EX-101.PRE	688545

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608

Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800

NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)